Lisa A Hark1,2, Jonathan S Myers3,4, Andrew Ines4, Alicia Jiang4, Kamran Rahmatnejad5, Tingting Zhan6, Benjamin E Leiby6, Sarah Hegarty6, Scott J Fudemberg3,4, Anand V Mantravadi3,4, Michael Waisbourd7, Jeffrey D Henderer8, Christine Burns5, Meskerem Divers5, Jeanne Molineaux5, Laura T Pizzi9, Ann P Murchison4,10, Jinan Saaddine11, Louis R Pasquale12, Julia A Haller4,13, L Jay Katz3,4. 1. Glaucoma Research Center, Wills Eye Hospital, Philadelphia, Pennsylvania, USA lah112@cumc.columbia.edu. 2. Ophthalmology, Columbia University Irving Medical Center, New York, New York, USA. 3. Glaucoma Service, Wills Eye Hospital, Philadelphia, Pennsylvania, USA. 4. Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. 5. Glaucoma Research Center, Wills Eye Hospital, Philadelphia, Pennsylvania, USA. 6. Division of Biostatistics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. 7. Ophthalmology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel. 8. Ophthalmology, Temple University Hospital, Philadelphia, Pennsylvania, USA. 9. School of Pharmacy, Rutgers University, Piscataway, New Jersey, USA. 10. Emergency Department, Wills Eye Hospital, Philadelphia, Pennsylvania, USA. 11. Centers for Disease Control and Prevention, Division of Diabetes Translation, Vision Health Initiative, Atlanta, Georgia, USA. 12. Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. 13. Wills Eye Hospital, Ophthalmologist-in-Chief, Philadelphia, Pennsylvania, USA.
Authors: Benjamin E Leiby; Sarah E Hegarty; Tingting Zhan; Jonathan S Myers; L Jay Katz; Julia A Haller; Michael Waisbourd; Christine Burns; Meskerem Divers; Jeanne Molineaux; Jeffrey Henderer; Charles Brodowski; Lisa A Hark Journal: Prev Chronic Dis Date: 2021-05-20 Impact factor: 2.830